Skip to Content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Health Highlights: July 23, 2019

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Ragu Pasta Sauces Recalled Due to Plastic... Read more

Medical today

FDA Approves Ruxience (rituximab-pvvr), a Biosimilar to Rituxan

July 23, 2019 - Pfizer Inc. today announced the United States (U.S.) Food and Drug Administration (FDA) has approved Ruxience (rituximab-pvvr), a biosimilar to... Read more

Senate Bill Would Reduce Drug Costs for Seniors

TUESDAY, July 23, 2019 -- A bill to reduce prescription drug costs for millions of Medicare recipients and lower federal and state health costs has been... Read more

USPSTF Reaffirms Benefit of Hep B Screening in Pregnant Women

TUESDAY, July 23, 2019 -- The U.S. Preventive Services Task Force (USPSTF) recommends screening pregnant women for hepatitis B virus (HBV) infection at their... Read more

Filgotinib Bests Placebo in Tx of Refractory Rheumatoid Arthritis

TUESDAY, July 23, 2019 -- Among patients with moderately to severely active rheumatoid arthritis (RA) resistant to previous therapy with biologic agents, a... Read more

2001 to 2017 Saw Increase in Suicides in African-American Teens

TUESDAY, July 23, 2019 -- From 2001 to 2017, the rate of suicides among African-American (AA) adolescents increased, according to a study published in the... Read more

Nonphysican Practitioners Filling Post-ACA Primary Care Gap

TUESDAY, July 23, 2019 -- Primary care practices may be relying on advanced practitioners (APs) to accommodate new Medicaid beneficiaries following the passage... Read more

Mediterranean Diet Has Big Benefits for Expectant Moms: Study

TUESDAY, July 23, 2019 -- Could following a Mediterranean diet during pregnancy help head off gestational diabetes and excess weight gain? A British study says... Read more

Medical today

Higher Cost of New Cholesterol Drugs Putting Patients at Risk: Study

TUESDAY, July 23, 2019 -- Heart attacks, strokes and other heart problems are more likely in high-risk patients denied access to cutting-edge... Read more

Medical today

FDA Grants First Approvals for Generic Versions of Lyrica

TUESDAY, July 23, 2019 -- Nine drug companies have received approval for the first generic versions of Lyrica (pregabalin), the U.S. Food and Drug... Read more

Medical today

AHA News: Early Pregnancy May Be a Prime Time to Promote Heart Health

TUESDAY, July 23, 2019 (American Heart Association News) -- Improving cardiovascular health during the early stages of pregnancy can lead not only to a... Read more

Medical today

Vertex Submits New Drug Application to the U.S. FDA for Triple Combination Regimen of VX-445 (Elexacaftor), Tezacaftor and Ivacaftor in Cystic Fibrosis

BOSTON--(BUSINESS WIRE)--Jul. 22, 2019-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the submission of a New Drug Application... Read more

Baxter Announces U.S FDA Approval of Myxredlin, the First and Only Ready-To-Use Insulin for IV Infusion

DEERFIELD, Ill. - July 22, 2019 Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S.... Read more

FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease

SUMMIT, N.J.--(BUSINESS WIRE) July 19, 2019 -- Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla... Read more

FDA Approves Recarbrio (imipenem, cilastatin, and relebactam) for the Treatment of Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections

KENILWORTH, N.J.--(BUSINESS WIRE)-- July 17, 2019 Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and... Read more

FDA Accepts File and Accelerates Review of Novartis Sickle Cell Disease Medicine Crizanlizumab (SEG101)

Basel, July 16, 2019 - Novartis today announced the US Food and Drug Administration (FDA) accepted the company's Biologics License Application (BLA) and... Read more

Astellas and Seattle Genetics Announce Submission of Biologics License Application to FDA for Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer

TOKYO and BOTHELL, Wash., July 16, 2019 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.,... Read more

FDA Approves AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder for Asthma

JERUSALEM and PARSIPPANY, N.J., July 15, 2019 – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug... Read more

FDA to Review Isatuximab as a Potential Treatment for Relapsed/Refractory Multiple Myeloma

PARIS – July 10, 2019 - The U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for isatuximab... Read more

Neurocrine Biosciences Announces FDA Acceptance of New Drug Application for Opicapone as an Adjunctive Treatment for Patients with Parkinson's Disease

SAN DIEGO, July 10, 2019 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that the U.S. Food and Drug... Read more

FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients with Idiopathic Pulmonary Fibrosis

SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced dosing of the first patient in the ZEPHYRUS... Read more

ViiV Healthcare Presents Positive 96-week Data from Phase III Study of Investigational Fostemsavir in Heavily Treatment-Experienced Patients with HIV at IAS 2019

London, UK, 22 July 2019 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as... Read more

Clinical Trials 2 days ago

Gilead Presents Proof-of-Concept Data for GS-6207, a First-in-Class Capsid Inhibitor, in People Living With HIV

FOSTER CITY, Calif.--(BUSINESS WIRE)--Jul. 22, 2019-- Gilead Sciences, Inc. (NASDAQ: GILD) today presented the first clinical data in people... Read more

Clinical Trials 2 days ago

Orphazyme to Prepare for Filing of Arimoclomol in US for Niemann-Pick Disease Type C (NPC)

Copenhagen, July 21, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with... Read more

Clinical Trials 2 days ago

Seelos Therapeutics Announces Investigational New Drug Application Submission for SLS-005

NEW YORK, July 17, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, announced today that it has... Read more

Clinical Trials 7 days ago